4-Methylamphetamine
| Clinical data | |
|---|---|
| Trade names | Aptrol | 
| Other names | 4-MA; PAL-313; PAL313; p-TAP; Normephedrine | 
| Routes of administration | Oral, intranasal, injection, | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Elimination half-life | 6–12 hours | 
| Excretion | Urine | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H15N | 
| Molar mass | 149.237 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (what is this?) (verify) | |
4-Methylamphetamine (4-MA), also known by the former proposed brand name Aptrol, is a stimulant and anorectic drug of the amphetamine family. It is structurally related to mephedrone (4-methylmethcathinone).